Table 2.
Nuclear grade1 | P value | Tumor size (cm)1 | p value | Ki67 (%)1,2 | P value | Pathologic stage1 | P value | ||||||
1,2 | 3,4 | < 7 | ≥ 7 | low | high | 1 | 2,3,4, | ||||||
HIF-1α | nHIF-1α | 49.5 | 39 | 0.006 | 48.6 | 43.6 | 0.057 | 43.9 | 48.1 | 0.134 | 48.1 | 44.5 | 0.165 |
(%) | (16.3–82.3) | (19.2–72.6) | (27.9–73.9) | (16.3–82.3) | (16.3–72.4) | (21.2–82.3) | (27.9–73.9) | (16.3–82.3) | |||||
cHIF-1α | 11.4 | 18.7 | 0.006 | 11.3 | 17.5 | 0.009 | 14.6 | 11.6 | 0.246 | 11.4 | 16.6 | 0.023 | |
(1.4–75) | (5.2–59.5) | (1.4–59.5) | (2.9–75) | (4.3–75) | (1.4–46.5) | (1.4–42.6) | (2.9–75) | ||||||
VEGF-A | pVEGF-A | 15 | 12.5 | 0.307 | 15 | 7.5 | 0.173 | 12.5 | 12.7 | 0.658 | 12.1 | 17.5 | 0.682 |
(%) | (0.00–94) | (0–75) | (0–94) | (0–75) | (0–94) | (0–75) | (0–94) | (0–75) | |||||
dVEGF-A | 6.7 | 30 | <0.001 | 6.7 | 16.7 | 0.015 | 10.6 | 10 | 0.652 | 6.3 | 11.7 | 0.027 | |
(0–92.5) | (0–90) | (0–67.5) | (0–92.5) | (0–92.5) | (0–83.3) | (0–76.7) | (0–92.5) | ||||||
VEGF-C | pVEGF-C | 65 | 14 | <0.001 | 64.2 | 27.9 | 0.007 | 45 | 55 | 0.913 | 61.3 | 33.3 | 0.042 |
(%) | (0–100) | (0–92.5) | (0–100) | (0–100) | (0–100) | (0–100) | (0–100) | (0–100) | |||||
dVEGF-C | 18.5 | 37 | 0.004 | 18 | 37.1 | 0.007 | 25 | 26.3 | 0.516 | 20 | 30 | 0.109 | |
(0–100) | (0–100) | (0–100) | (0–100) | (0–100) | (0–100) | (0–100) | (0–100) |
1Mann-Whitney U-test; median (range); 2cut-off is mean